BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3037504)

  • 1. [Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
    Halawa B
    Pol Tyg Lek; 1987 Feb; 42(6):153-5. PubMed ID: 3037504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-blockers in effort angina].
    Witchitz S; Kolsky H; Moisson P; Philippe B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension].
    Tacquet A
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3294-6. PubMed ID: 768913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind trial of propranolol and pindolol in angina pectoris.
    Ilyas M; Jafary MH; Peracha MA; Janjua M; Khan N
    J Pak Med Assoc; 1975 Jul; 25(7):165-6. PubMed ID: 815634
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative effectiveness of various beta adrenergic blockaders in hypertension].
    Povetkin SV
    Sov Med; 1991; (4):94. PubMed ID: 1871651
    [No Abstract]   [Full Text] [Related]  

  • 12. [beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
    Dubois D; Petitcolas J
    Nouv Presse Med; 1978 Sep; 7(31):2811-2. PubMed ID: 30971
    [No Abstract]   [Full Text] [Related]  

  • 13. A cross-over trial comparing the effects of acebutolol and propranolol on the serum lipids and hypertension.
    Ghosh DC; Dutta S; Sarkar N
    Indian Heart J; 1989; 41(5):292-5. PubMed ID: 2599537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the action of beta-blockers and calcium inhibitors in the treatment of primary angina pectoris].
    Bory M; BĂ©nichou M
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():153-9. PubMed ID: 6134506
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 17. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment by beta-blockers of arterial hypertension in patients with chronic renal insufficiency on hemodialysis].
    Fillastre JP; Godin M
    Nouv Presse Med; 1978 Sep; 7(31):2799-801. PubMed ID: 30968
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of physical load and brief monotherapy with obsidan on the characteristics of beta 2-adrenoreceptors of intact lymphocytes in patients with hypertension].
    Parfenova EV; Nauman E; Korichneva IL; Suvorov IuI; Aripova NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):60-8. PubMed ID: 2840928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.